Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 16;10:544789. doi: 10.3389/fonc.2020.544789

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 Xu, Cheng, Fan and Mao.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Correlation of stromal scores and immune scores with the overall survival and relapse-free survival in malignant pleural mesothelioma (MPM) using the dataset in The Cancer Genome Atlas (TCGA) database. MPM patients were divided into two groups based on their stromal scores. As shown in the Kaplan–Meier survival curve, the low stromal score group has significantly longer overall survival (A) and relapse-free survival than the high stromal score group (B), as indicated by the log-rank test; p-value is 0.006 and 0.022, respectively. MPM patients were divided into two groups based on their immune scores. The high-immune-score group has significantly longer overall survival (C) and relapse-free survival (D) than the low-immune-score group; the log-rank test p = 0. 015 and p = 0.011.